Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-09-16 Sale |
2024-09-18 5:46 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $16.33 | $8,165 | 17,160 (Direct) |
View |
2024-08-19 Sale |
2024-08-21 4:28 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $15 | $7,500 | 17,660 (Direct) |
View |
2024-07-16 Sale |
2024-07-18 8:22 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $27.11 | $47,443 | 50,662 (Direct) |
View |
2024-07-11 Sale |
2024-07-15 6:13 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,996 | $25 | $49,900 | 29,785 (Direct) |
View |
2024-07-10 Sale |
2024-07-12 5:46 pm |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
12,923 | $22.49 | $290,598 | 1,773,300 (Direct) |
View |
2024-07-01 Sale |
2024-07-03 5:11 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
4,248 | $21.36 | $90,758 | 47,368 (Direct) |
View |
2024-06-24 Sale |
2024-06-26 5:07 pm |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
12,930 | $23.1 | $298,711 | 1,636,223 (Direct) |
View |
2024-06-17 Sale |
2024-06-20 4:59 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $23.71 | $41,494 | 51,616 (Direct) |
View |
2024-05-16 Sale |
2024-05-20 8:35 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $25.45 | $44,541 | 53,366 (Direct) |
View |
2024-04-16 Sale |
2024-04-18 8:48 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $25.74 | $45,045 | 55,116 (Direct) |
View |
2024-04-01 Sale |
2024-04-03 7:18 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
8,153 | $31.78 | $259,102 | 124,056 (Direct) |
View |
2024-03-27 Sale |
2024-03-29 4:52 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
5,833 | $35.04 | $204,410 | 111,562 (Direct) |
View |
2024-03-18 Sale |
2024-03-20 4:40 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $31.27 | $54,723 | 61,114 (Direct) |
View |
2024-02-27 Sale |
2024-02-29 6:01 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,909 | $30 | $57,270 | 49,828 (Direct) |
View |
2024-02-16 Sale |
2024-02-21 5:41 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $27.67 | $48,423 | 62,864 (Direct) |
View |
2024-02-08 Sale |
2024-02-12 9:04 pm |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
6,244 | $27.5 | $171,710 | 87,618 (Direct) |
View |
2024-02-08 Sale |
2024-02-12 8:22 pm |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
92,001 | $27.13 | $2,495,822 | 1,059,153 (Direct) |
View |
2024-02-05 Sale |
2024-02-07 8:32 pm |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
24,552 | $30.05 | $737,788 | 257,043 (Direct) |
View |
2024-01-23 Sale |
2024-01-25 4:59 pm |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
5,696 | $18.41 | $104,851 | 1,151,154 (Direct) |
View |
2023-12-15 Sale |
2024-01-08 4:19 pm |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
102,303 | $19.15 | $1,959,354 | 1,156,850 (Direct) |
View |
2024-01-04 Sale |
2024-01-05 5:44 pm |
4D Molecular Therapeutics Inc. | FDMT | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
540,000 | $19.53 | $10,546,200 | 4,247,914 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-06 Option Award |
2025-03-10 8:00 pm |
N/A 2035-03-05 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
78,500 | $0 | 78,500 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 7:58 pm |
N/A 2035-03-05 |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
267,500 | $0 | 267,500 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 7:58 pm |
N/A 2035-03-05 |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
92,300 | $0 | 92,300 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 7:57 pm |
N/A 2035-03-05 |
4D Molecular Therapeutics Inc. | FDMT | Mehra Uneek See Remarks |
130,000 | $0 | 130,000 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 7:56 pm |
N/A 2035-03-05 |
4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President & COO |
178,400 | $0 | 178,400 (Direct) |
View |
2024-12-09 Other |
2024-12-10 4:28 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
535,000 | $0 | 8,708,211 (Indirect) |
View |
Ownership |
2024-11-25 4:33 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 11,810,641 (Indirect) |
View |
2024-11-08 Other |
2024-11-13 4:33 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
5,680,000 | $0 | 11,447,911 (Direct) |
View |
2024-09-16 Exercise |
2024-09-18 5:46 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $0 | 17,160 (Direct) |
View |
2024-09-16 Exercise |
2024-09-18 5:46 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 17,160 (Direct) |
View |
2024-08-19 Exercise |
2024-08-21 4:28 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $0 | 17,660 (Direct) |
View |
2024-08-19 Exercise |
2024-08-21 4:28 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 17,660 (Direct) |
View |
Ownership |
2024-08-01 4:06 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
0 | $0 | 7,261,118 (Direct) |
View |
2024-07-16 Exercise |
2024-07-18 8:22 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $0 | 50,662 (Direct) |
View |
2024-07-16 Exercise |
2024-07-18 8:22 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,250 | $8.04 | 50,662 (Direct) |
View |
2024-07-16 Exercise |
2024-07-18 8:22 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 50,662 (Direct) |
View |
2024-07-11 Exercise |
2024-07-15 6:13 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,996 | $15.78 | 29,785 (Direct) |
View |
2024-07-11 Exercise |
2024-07-15 6:13 pm |
N/A 2032-01-31 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,996 | $0 | 29,785 (Direct) |
View |
2024-07-10 Exercise |
2024-07-12 5:46 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
1,270 | $15.78 | 1,773,300 (Direct) |
View |
2024-07-10 Exercise |
2024-07-12 5:46 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
11,653 | $14.42 | 1,773,300 (Direct) |
View |
2024-07-10 Exercise |
2024-07-12 5:46 pm |
N/A 2033-12-10 |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
12,923 | $0 | 1,773,300 (Direct) |
View |
2024-07-01 Exercise |
2024-07-03 5:11 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
4,248 | $0 | 47,368 (Direct) |
View |
2024-07-01 Exercise |
2024-07-03 5:11 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
2,916 | $8.04 | 47,368 (Direct) |
View |
2024-07-01 Exercise |
2024-07-03 5:11 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,332 | $6.49 | 47,368 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 5:07 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
12,930 | $14.42 | 1,636,223 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 5:07 pm |
N/A 2033-12-10 |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
12,930 | $0 | 1,636,223 (Direct) |
View |
2024-06-17 Exercise |
2024-06-20 4:59 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $0 | 51,616 (Direct) |
View |
2024-06-17 Exercise |
2024-06-20 4:59 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,250 | $8.04 | 51,616 (Direct) |
View |
2024-06-17 Exercise |
2024-06-20 4:59 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 51,616 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 8:45 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director |
22,500 | $0 | 22,500 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 7:17 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director |
22,500 | $0 | 22,500 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 7:16 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director |
22,500 | $0 | 22,500 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 7:12 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 7:11 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director |
26,791 | $0 | 26,791 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 7:10 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director |
22,500 | $0 | 22,500 (Direct) |
View |
2024-05-16 Exercise |
2024-05-20 8:35 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $0 | 53,366 (Direct) |
View |
2024-05-16 Exercise |
2024-05-20 8:35 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,250 | $8.04 | 53,366 (Direct) |
View |
2024-05-16 Exercise |
2024-05-20 8:35 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 53,366 (Direct) |
View |
2024-04-16 Exercise |
2024-04-18 8:48 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $0 | 55,116 (Direct) |
View |
2024-04-16 Exercise |
2024-04-18 8:48 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,250 | $8.04 | 55,116 (Direct) |
View |
2024-04-16 Exercise |
2024-04-18 8:48 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 55,116 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 7:18 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,909 | $20.24 | 124,056 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 7:18 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,996 | $15.78 | 124,056 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 7:18 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
8,153 | $0 | 124,056 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 7:18 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
2,916 | $8.04 | 124,056 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 7:18 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,332 | $6.49 | 124,056 (Direct) |
View |
2024-03-27 Exercise |
2024-03-29 4:52 pm |
N/A 2031-09-30 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
5,833 | $0 | 111,562 (Direct) |
View |
2024-03-27 Exercise |
2024-03-29 4:52 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
5,833 | $25.98 | 111,562 (Direct) |
View |
2024-03-18 Exercise |
2024-03-20 4:40 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $0 | 61,114 (Direct) |
View |
2024-03-18 Exercise |
2024-03-20 4:40 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,250 | $8.04 | 61,114 (Direct) |
View |
2024-03-18 Exercise |
2024-03-20 4:40 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 61,114 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 6:01 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,909 | $20.24 | 49,828 (Direct) |
View |
2024-02-27 Exercise |
2024-02-29 6:01 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,909 | $0 | 49,828 (Direct) |
View |
2024-02-16 Exercise |
2024-02-21 5:41 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,750 | $0 | 62,864 (Direct) |
View |
2024-02-16 Exercise |
2024-02-21 5:41 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,250 | $8.04 | 62,864 (Direct) |
View |
2024-02-16 Exercise |
2024-02-21 5:41 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
500 | $6.49 | 62,864 (Direct) |
View |
2024-02-08 Exercise |
2024-02-12 9:04 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,996 | $15.78 | 87,618 (Direct) |
View |
2024-02-08 Exercise |
2024-02-12 9:04 pm |
N/A 2032-06-17 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
6,244 | $0 | 87,618 (Direct) |
View |
2024-02-08 Exercise |
2024-02-12 9:04 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
2,916 | $8.04 | 87,618 (Direct) |
View |
2024-02-08 Exercise |
2024-02-12 9:04 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer |
1,332 | $6.49 | 87,618 (Direct) |
View |
2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
6,000 | $15.78 | 257,043 (Direct) |
View |
2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
12,000 | $18.66 | 257,043 (Direct) |
View |
2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A 2030-11-08 |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
24,000 | $0 | 257,043 (Direct) |
View |
2024-02-05 Exercise |
2024-02-07 8:32 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
6,000 | $8.04 | 257,043 (Direct) |
View |
Ownership(A) |
2024-02-07 7:42 pm |
N/A N/A |
4D Molecular Therapeutics Inc. | FDMT | Kim Robert Young Chief Medical Officer |
0 | $0 | 1,595 (Direct) |
View |
2023-12-11 Option Award |
2023-12-13 4:05 pm |
N/A 2033-12-10 |
4D Molecular Therapeutics Inc. | FDMT | Mehra Uneek See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
2023-12-11 Option Award |
2023-12-13 4:05 pm |
N/A 2033-12-10 |
4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal and HR Officer |
130,000 | $0 | 130,000 (Direct) |
View |
2023-12-11 Option Award |
2023-12-13 4:05 pm |
N/A 2033-12-10 |
4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer |
590,000 | $0 | 590,000 (Direct) |
View |